Friday, October 9, 2026
Home Authors Posts by Ogkologos

Ogkologos

4364 POSTS 0 COMMENTS

Adjuvant Alectinib Significantly Improves Disease-Free Survival in Patients with Resected ALK-positive...

Ogkologos -
0

Adding Gemcitabine to Cisplatin Once per Week Concurrently with IMRT Significantly...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Biosimilar Denosumab

Ogkologos -
0

Studies Assess Impact of Cancer Risk-Reduction Measures for People with BRCA...

Ogkologos -
0

A Novel Model Helps Better Predict Risk of Cancer Development in...

Ogkologos -
0

New on NCI’s Websites for April 2024

Ogkologos -
0

FDA Grants Accelerated Approval to fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic...

Ogkologos -
0

Favourable Response More Likely with Neoadjuvant Dual Immune Checkpoint Inhibitor Than...

Ogkologos -
0

Neoadjuvant Chemoimmunotherapy Superior to Neoadjuvant Chemotherapy with Event-Free Survival Benefit in...

Ogkologos -
0

FDA Approves Mirvetuximab Soravtansine-gynx for FRα-positive, Platinum-resistant Epithelial Ovarian, Fallopian Tube,...

Ogkologos -
0
1...828384...437Page 83 of 437

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com